These findings indicated that CDKN2A functions from the perspective of tumor cells since it is significantly up-regulated in metastatic UCEC, and its knockdown attenuates the ability of tumor cells to invade metastases in vitro and in vivo. The gene discussed is CDKN2A; the disease is neoplasm.